BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 531611)

  • 1. [Experience in the use of the Soviet drug riboxin in therapeutic practice].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Ovchinnikova LV; Pogromov AP
    Sov Med; 1979 Dec; (12):82-3. PubMed ID: 531611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of riboxin in treating patients with chronic ischemic heart disease].
    Lanovaia NI; Neĭko EM
    Vrach Delo; 1986 Aug; (8):17-9. PubMed ID: 3776150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
    Kurdybaĭlo FV; Larina IG; Kulikova AN
    Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
    Rudyk BI
    Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H; Zwirner K; Herzog W
    Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with P-Carboxyphenylglycylaminoacetonitrile in refractory].
    Ota Y; Endo H
    Saishin Igaku; 1969 Jan; 24(1):185-7. PubMed ID: 5777190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.